MZE 001
Alternative Names: MZE-001Latest Information Update: 17 May 2024
At a glance
- Originator Maze Therapeutics
- Class Small molecules
- Mechanism of Action Glycogen synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Glycogen storage disease type II